CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04062708 |
Recruitment Status :
Active, not recruiting
First Posted : August 20, 2019
Last Update Posted : February 5, 2024
|
Sponsor:
Alliance Foundation Trials, LLC.
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Alliance Foundation Trials, LLC.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | December 2025 |
Estimated Study Completion Date : | June 2026 |
Publications: